New Targets of Neuroprotection in Ischemic Stroke
Ischemic stroke represents one of the most challenging diseases in translational neurology. Despite the considerable efforts made to develop efficacious therapies that prevent damage once a stroke has occurred, there are still no established treatments for humans. The only available treatment is int...
Saved in:
Main Authors: | Marco Bacigaluppi, Dirk M. Hermann |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2008.94 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroprotective Effects of Stem Cells in Ischemic Stroke
by: Weilin Xu, et al.
Published: (2017-01-01) -
Nonhematopoietic Variants of Erythropoietin in Ischemic Stroke: Need for Step-Wise Proof-of-Concept Studies
by: Dirk M. Hermann
Published: (2010-01-01) -
Corrigendum: Neuroprotection by cattle encephalon glycoside and ignotin beyond the time window of thrombolysis in ischemic stroke
Published: (2025-12-01) -
Neuroprotective Efficacy of <i>Astragalus mongholicus</i> in Ischemic Stroke: Antioxidant and Anti-Inflammatory Mechanisms
by: Yongjae Hong, et al.
Published: (2025-01-01) -
A new taxonomy of neuroprotective agents for stroke appropriate for the reperfusion era
by: Mersedeh Bahr-Hosseini, et al.
Published: (2025-02-01)